MedTrace Logo

Efficacy Study of Patient Preoperative Preps In-vivo

NCT04756154 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 154

Last updated 2024-10-01

Study results available
· View outcomes & findings →

Summary

The purpose of this study is to determine the antimicrobial efficacy of an investigational CHG/IPA prep on skin flora of the inguinal regions of human subjects.

Conditions

  • Surgical Skin Preparation

Interventions

DRUG

CHG/IPA Surgical skin preparation

Apply topically to the inguinal region for 2 minutes

DRUG

Normal saline

Apply topically to the inguinal region for 2 minutes

Sponsors & Collaborators

  • 3M

    collaborator INDUSTRY

  • Solventum US LLC

    lead INDUSTRY

Principal Investigators

  • Muhammad H Bashir, MD, CCRP · Microbac

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2020-07-06
Primary Completion
2021-04-28
Completion
2021-04-28
FDA Drug
Yes

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04756154 on ClinicalTrials.gov